We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NVCR market cap is 1.71B. The company's latest EPS is USD -1.5342 and P/E is -10.16.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 133.78M | 138.5M | 150.36M | 155.1M | 161.27M |
| Operating Income | -53.9M | -40.91M | -32.93M | -32.6M | -64.07M |
| Net Income | -47.08M | -38.76M | -33.38M | -30.57M | -65.92M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 494.37M | 535.03M | 537.84M | 509.34M | 605.22M |
| Operating Income | 30.4M | -44.33M | -89.52M | -232.87M | -170.5M |
| Net Income | 19.81M | -58.35M | -92.53M | -207.04M | -168.63M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.15B | 1.12B | 1.21B | 1.22B | 1.24B |
| Total Liabilities | 783.63M | 762.07M | 850.42M | 861.21M | 880.61M |
| Total Equity | 362.5M | 359.36M | 361.75M | 360.78M | 360.18M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.05B | 1.14B | 1.19B | 1.15B | 1.24B |
| Total Liabilities | 575.46M | 729M | 750.48M | 783.63M | 880.61M |
| Total Equity | 476.53M | 410.49M | 441.17M | 362.5M | 360.18M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -73.34M | -31.57M | -33.29M | -22.92M | -26.37M |
| Investing | 184.15M | 246.22M | -128.22M | -118.03M | -140.24M |
| Financing | 15.79M | 213k | 87.53M | 87.63M | 90.32M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 99.15M | 82.76M | 30.79M | -73.34M | -26.37M |
| Investing | -472.85M | -144.83M | -139.96M | 184.15M | -140.24M |
| Financing | 440.21M | 25.7M | 15.49M | 15.79M | 90.32M |
| Market Cap | 1.71B |
| Price to Earnings Ratio | -10.16 |
| Price to Sales Ratio | 2.83 |
| Price to Cash Ratio | 10.46 |
| Price to Book Ratio | 4.76 |
| Dividend Yield | - |
| Shares Outstanding | 109.92M |
| Average Volume (1 week) | 693.46k |
| Average Volume (1 Month) | 715.75k |
| 52 Week Change | 27.93% |
| 52 Week High | 34.13 |
| 52 Week Low | 11.70 |
| Spread (Intraday) | 0.39 (2.49%) |
| Company Name | NovoCure Ltd |
| Address |
no 4 the forum jersey JE2 4UF |
| Website | https://www.novocure.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
